Back to Search
Start Over
Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline-deprived myocardium: the effects of carnitine.
- Source :
-
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2016 Feb; Vol. 30 (1), pp. 47-57. Date of Electronic Publication: 2015 Dec 08. - Publication Year :
- 2016
-
Abstract
- Choline has been identified as an essential nutrient with crucial role in many vital biological functions. Recent studies have demonstrated that heart dysfunction can develop in the setting of choline deprivation even in the absence of underlying heart disease. Matrix metalloproteinases (MMPs) are responsible for extracellular matrix degradation, and the dysregulation of MMP-2 and MMP-9 has been involved in the pathogenesis of various cardiovascular disorders. The aim of the study was to investigate the role of MMPs and their inhibitors (TIMPs), in the pathogenesis of choline deficiency-induced cardiomyopathy, and the way they are affected by carnitine supplementation. Male Wistar Albino adult rats were divided into four groups and received standard or choline-deficient diet with or without L-carnitine in drinking water (0.15% w/v) for 1 month. Heart tissue immunohistochemistry for MMP-2, MMP-9, TIMP-1, and TIMP-2 was performed. Choline deficiency was associated with suppressed immunohistochemical expression of MMP-2 and an increased expression of TIMP-2 compared to control, while it had no impact on TIMP-1. MMP-9 expression was decreased without, however, reaching statistical significance. Carnitine did not affect MMP-2, MMP-9, TIMP-1 or TIMP-2 expression. The pattern of TIMP and MMP modulation observed in a choline deficiency setting appears to promote fibrosis. Carnitine, although shown to suppress fibrosis, does not seem to affect MMP-2, MMP-9, TIMP-1 or TIMP-2 expression. Further studies will be required to identify the mechanism underlying the beneficial effects of carnitine.<br /> (© 2015 Société Française de Pharmacologie et de Thérapeutique.)
- Subjects :
- Administration, Oral
Animals
Cardiomyopathies etiology
Cardiomyopathies metabolism
Cardiomyopathies pathology
Carnitine administration & dosage
Choline Deficiency complications
Choline Deficiency metabolism
Choline Deficiency pathology
Disease Models, Animal
Extracellular Matrix pathology
Fibrosis
Immunohistochemistry
Male
Matrix Metalloproteinase 2 biosynthesis
Matrix Metalloproteinase 9 biosynthesis
Myocardium pathology
Rats, Wistar
Tissue Inhibitor of Metalloproteinase-1 biosynthesis
Tissue Inhibitor of Metalloproteinase-2 biosynthesis
Cardiomyopathies prevention & control
Carnitine therapeutic use
Choline Deficiency drug therapy
Extracellular Matrix metabolism
Myocardium metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1472-8206
- Volume :
- 30
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Fundamental & clinical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 26501493
- Full Text :
- https://doi.org/10.1111/fcp.12163